A novel, automated periostin assay; correlation with a commercial ELISA method and usability as an asthma biomarker

Masayuki Takai (Sagamihara, Japan), Masayuki Takai, Junya Ono, Ayami Kamei, Hisako Matsumoto, Shoichiro Ohta, Kenji Izuhara

Source: International Congress 2016 – Clinical and molecular studies in asthma
Session: Clinical and molecular studies in asthma
Session type: Oral Presentation
Number: 1980
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Masayuki Takai (Sagamihara, Japan), Masayuki Takai, Junya Ono, Ayami Kamei, Hisako Matsumoto, Shoichiro Ohta, Kenji Izuhara. A novel, automated periostin assay; correlation with a commercial ELISA method and usability as an asthma biomarker. Eur Respir J 2016; 48: Suppl. 60, 1980

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A new investigational use only automated immunoassay for periostin
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015

Performance evaluation of a novel point-of-care total IgE assay system in atopic patients
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016

Performance characteristics of an ECL immunoassay for the quantitation of serum periostin
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016


A solution to small samples: A method validation study for sputum assay
Source: International Congress 2014 – More paediatric asthma
Year: 2014


Usefulness of periostin as a biomarker of pediatric asthma
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015


Diagnostic accuracy of markers for detection of airway eosinophilia in asthma: A systematic review
Source: International Congress 2014 – Airway biomarkers
Year: 2014


Comparison of the analytical performance of the Euroline®, ImmunoCAP®, and ImmunoCAP ISAC 112® in vitro allergen sIgE diagnostic assays in the pediatric arm of the DZL All Age Asthma Cohort (ALLIANCE)
Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools
Year: 2018


A new method for performing specific challenge tests to chlorine-releasing agents
Source: International Congress 2016 – Occupational epidemiology
Year: 2016


Novel proteomic biomarkers in the evaluation of childhood asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Methacholine challenge test in asthma: Serial measurement and clinical significance
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013


Usefulness of exhaled breath condensate as non-invasive method of evaluating of biomarkers in severe asthma patients
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014


Refined severity assessment of asthmatic children using molecular allergy diagnostics
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013

Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014


Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015


Unbiased cluster analysis of severe asthma based on metabolomics by the U-BIOPRED electronic nose platform
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013


Sputum YKL-40 is a potential biomarker of COPD-asthma overlap
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014


A new observer independent method to assess therapy response in children with severe asthma based on daily lung function
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013


LATE-BREAKING ABSTRACT: The study of fibulin-1 as a novel biomarker in bronchial asthma and its association to disease severity
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015


Asthma phenotypes determined by a novel fluctuation based clustering method using a time window of lung function observations
Source: International Congress 2015 – Understanding paediatric asthma and allergy: genetics and environment
Year: 2015

Proteome fingerprints define groups with distinct clinico-pathological phenotypes in the U-BIOPRED asthma study
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016